Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
Links shared publicly online about this topic.
- 1,693total visits
Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia
Welchol (colesevelam HCl) is used to treat Pediatric Patients with Heterozygous Familial Hypercholesterolemia. Includes Welchol side effects, interactions and indications.
View full resource at drugs.com
Tags: Cholesterol, Children's Health, FDA
Most Recently Shared on October 7, 2009 at 10:47 pm By:
FDA Approves Welchol for Pediatric Patients with Heterozygous Familial Hypercholesterolemia - http://bit.ly/BU6lG
Advertisement
